Quantum Biopharma (QNTM) Cash & Current Investments (2018 - 2026)

Quantum Biopharma's Cash & Current Investments history runs 9 years deep, the most recent figure standing at $2.1 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 64.63% year-over-year to $2.1 million; the TTM figure through Mar 2026 stood at $2.1 million (down 64.63% YoY), while the FY2025 annual figure was $2.4 million, down 67.15% from the prior year.
• Cash & Current Investments came in at $2.1 million for Q1 2026 at Quantum Biopharma, down from $2.4 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $32.0 million in Q2 2022 to a low of $2.1 million in Q1 2026.
• A 5-year average of $10.6 million and a median of $6.1 million in 2023 frame the typical range for Cash & Current Investments.
• Across the five-year window, Cash & Current Investments sank 87.84% in 2023 and surged 120.0% in 2025, its largest moves.
• Quantum Biopharma's Cash & Current Investments stood at $17.0 million in 2022, then plunged by 82.98% to $2.9 million in 2023, then jumped by 149.12% to $7.2 million in 2024, then sank by 67.15% to $2.4 million in 2025, then decreased by 9.99% to $2.1 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $2.1 million, $2.4 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison